Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma.

Bang, Jieun; Jun, Mihyeon; Lee, Soyun; Moon, Hyuk; Ro, Simon Weonsang

Bang, Jieun; Jun, Mihyeon; Lee, Soyun; Moon, Hyuk; Ro, Simon Weonsang.

Afiliação

Bang J; Department of Genetics and Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Republic of Korea.
Jun M; Department of Genetics and Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Republic of Korea.
Lee S; Department of Genetics and Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Republic of Korea.
Moon H; Department of Genetics and Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Republic of Korea.
Ro SW; Department of Genetics and Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si 17104, Republic of Korea.

Pharmaceutics ; 15(8)2023 Aug 14.

Article em En | MEDLINE | ID: mdl-37631344

Palavras-chave

EGFR/PI3K/AKT/mTOR signaling; animal models; hepatocellular carcinoma; targeted therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article